Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0X5XB
|
|||
Drug Name |
US8741907-compound-3
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C17H26N4O
|
|||
Canonical SMILES |
CCC(CC)N1C2=C(C=N1)C(=O)NC(=N2)CC3CCCCC3
|
|||
InChI |
1S/C17H26N4O/c1-3-13(4-2)21-16-14(11-18-21)17(22)20-15(19-16)10-12-8-6-5-7-9-12/h11-13H,3-10H2,1-2H3,(H,19,20,22)
|
|||
InChIKey |
GXWSVMJGLJNVHK-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Phosphodiesterase 3B (PDE3B) | Target Info | Inhibitor | [1] |
Target's Patent Info | Phosphodiesterase 3B (PDE3B) | Target's Patent Info | [1] | |
NetPath Pathway | TCR Signaling Pathway | |||
IL2 Signaling Pathway | ||||
Pathway Interaction Database | Class IB PI3K non-lipid kinase events |
References | Top | |||
---|---|---|---|---|
REF 1 | Selective phosphodiesterase 9A inhibitors as medicaments for improving cognitive processes. US9067945. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.